What short-acting glucocorticoids are available and what are their typical dosing regimens for acute adrenal insufficiency, severe allergic reactions, or asthma exacerbations?

Short-Acting Corticosteroids: Available Agents and Dosing

The primary short-acting glucocorticoids are hydrocortisone, prednisone, prednisolone, and methylprednisolone, with hydrocortisone being the shortest-acting and preferred for acute adrenal insufficiency, while prednisone/prednisolone are commonly used for allergic reactions and asthma exacerbations.

Classification by Duration of Action

Short-acting glucocorticoids are distinguished from long-acting agents (dexamethasone, betamethasone) by their biological half-life and duration of HPA axis suppression. When transitioning off glucocorticoid therapy, patients should be switched from long-acting to shorter-acting agents 1.

Available Short-Acting Agents with Equivalent Dosing

The physiologic daily dose equivalents are 1:

• Hydrocortisone: 15-25 mg/day (shortest-acting)
• Prednisone/Prednisolone: 4-6 mg/day (used interchangeably)
• Methylprednisolone: 3-5 mg/day

These doses represent the equivalent of normal daily cortisol production (9-10 mg/day endogenous cortisol).

Clinical Applications and Dosing Regimens

Acute Adrenal Insufficiency (Adrenal Crisis)

For adrenal crisis, hydrocortisone is the agent of choice at 10-15 times physiological doses 2:

• Initial dose: Hydrocortisone 100 mg IV bolus (approximately 4 mg/kg for adults)
• Maintenance: Hydrocortisone 12 mg/kg over 24 hours as continuous infusion, OR
• Alternative bolus regimen: Methylprednisolone 125 mg IV every 6 hours 3

Critical caveat: If peripheral IV access cannot be obtained rapidly, administer intramuscularly without delay 2. If hydrocortisone is unavailable, prednisolone or methylprednisolone may be substituted 2.

Severe Allergic Reactions/Anaphylaxis

Glucocorticoids are adjunctive therapy in anaphylaxis and do not provide immediate benefit - epinephrine remains first-line 4. However, they may prevent biphasic or protracted reactions:

• IV route (severe/prolonged anaphylaxis): Methylprednisolone 1.0-2.0 mg/kg/day IV every 6 hours 4
• Oral route (less critical episodes): Prednisone 0.5 mg/kg orally 4

Important limitation: Systemic glucocorticosteroids are typically not helpful acutely but are considered for patients with history of idiopathic anaphylaxis and asthma, or those experiencing severe/prolonged reactions 4.

Asthma Exacerbations

For acute asthma exacerbations, multiple short-course regimens show equivalent efficacy 5:

Traditional Regimens:

• Prednisone/Prednisolone: 0.5-1 mg/kg/day (maximum 60 mg/day) for 5-7 days 6
• Alternative: 1.0 mg/kg/day for 3 days
• Higher dose: 2.0 mg/kg/day for 5 days

Shorter Alternative:

• Dexamethasone: 0.3-0.6 mg/kg/day for 1-2 days 5

Network meta-analysis findings: No significant differences in relapse rates between short-course dexamethasone (1-2 days) versus longer prednisone courses (3-5 days), suggesting dexamethasone may be an acceptable alternative 5. However, dexamethasone is long-acting and should be reserved for acute treatment only, not chronic management 1.

Duration Definitions and Risk Thresholds

Short-term glucocorticoid therapy is defined as <3-4 weeks duration 1. This distinction is critical because:

• <3-4 weeks at any dose: Can be stopped abruptly without tapering or HPA axis testing 1
• ≥3-4 weeks at supraphysiologic doses (>15-25 mg hydrocortisone equivalent): Requires consideration of HPA axis suppression and potential need for taper 1

Safety Considerations

Even short-term systemic corticosteroids carry risks of serious adverse events, including sepsis, pneumonia, gastrointestinal bleeding, venous thromboembolism, and fracture 7. These risks appear earlier than previously recognized, necessitating judicious prescribing.

Supraphysiologic dosing threshold: Any dose exceeding the physiologic equivalent (>25 mg hydrocortisone, >6 mg prednisone, >5 mg methylprednisolone daily) carries increased risk, with mortality risk significantly elevated at prednisone >5 mg/day 1.

Practical Algorithm for Agent Selection

1. Acute adrenal crisis: Hydrocortisone IV/IM (first choice) or methylprednisolone
2. Anaphylaxis adjunct: Methylprednisolone IV or prednisone PO depending on severity
3. Asthma exacerbation: Prednisone/prednisolone PO (traditional) or dexamethasone PO (shorter alternative)
4. Chronic replacement: Hydrocortisone only (mimics physiologic cortisol rhythm)

Key principle: Match the agent's duration of action to clinical need - use shortest-acting agent that achieves therapeutic goal 1.